Name (Synonyms) | Correlation | |
---|---|---|
D001997 | Bronchopulmonary Dysplasia NIH | 1.00 |
D008595 | Menorrhagia NIH | 1.00 |
D006470 | Hemorrhage NIH | 1.00 |
D006929 | Hyperaldosteronism NIH | 1.00 |
D014552 | Urinary Tract Infections NIH | 1.00 |
D000309 | Adrenal Insufficiency NIH | 1.00 |
D054559 | Hyperphosphatemia NIH | 1.00 |
D007008 | Hypokalemia NIH | 1.00 |
D006973 | Hypertension NIH | 0.35 |
D003141 | Communicable Diseases NIH | 0.10 |
D007239 | Infection NIH | 0.07 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0000132 | Menorrhagia HPO | 1.00 |
HP:0002905 | Hyperphosphatemia HPO | 1.00 |
HP:0002900 | Hypokalemia HPO | 1.00 |
HP:0000846 | Adrenal insufficiency HPO | 1.00 |
HP:0000859 | Hyperaldosteronism HPO | 1.00 |
HP:0000822 | Hypertension HPO | 0.38 |
There is one clinical trial.
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.